Name: SRT3-22.5 Slow Release T3 (22.5mcg)
Brand: Chronic Illness Research
Price: 55.00 USD
Availability: InStock

Question 1

Is SRT3-22.5 Slow Release T3 (22.5mcg) legal in Canada?

Accepted Answer

SRT3-22.5 Slow Release T3 (22.5mcg) is sold strictly for research and development purposes in Canada. It is not approved by Health Canada for human consumption. Purchasers are responsible for compliance with local regulations.

Question 2

How is SRT3-22.5 Slow Release T3 (22.5mcg) shipped?

Accepted Answer

Canadian orders ship discreetly via Canada Post ($25 USD flat rate per batch of 6 items, 3-7 business days). International orders ship via Canada Post International ($45 USD flat rate per batch, 10-21 business days). Cold-chain integrity is maintained throughout transit and full tracking is included on every order.

Question 3

What form does SRT3-22.5 Slow Release T3 (22.5mcg) arrive in?

Accepted Answer

The product arrives as lyophilized (freeze-dried) powder in a sealed vial, ready for reconstitution with bacteriostatic water before use.

Question 4

How should SRT3-22.5 Slow Release T3 (22.5mcg) be stored?

Accepted Answer

Store the lyophilized powder at -20°C for long-term stability. Once reconstituted, store at 2–8°C (refrigerator) and use within 30 days. Avoid repeated freeze-thaw cycles.

Question 5

What payment methods are accepted?

Accepted Answer

We accept Bitcoin via BTCPay Server (no processing fee) and PayPal (20% surcharge). Bitcoin offers private, low-fee transactions; PayPal offers familiarity and buyer protection.

SRT3-22.5 Slow Release T3 (22.5mcg)

Molecular Characteristics

Cold-Chain Secure Logistics